Addex Therapeutics
Price & Volume
Stats
See more52W Range | $6.51-$12.04 |
Market Cap | $8.7M |
Shares Short | 5,030 |
Financials
See moreRevenue (12 Mos) | $158,538 |
Revenue Growth (YoY) | -15% |
Gross Profit (12 Mos) | -$525,653 |
Diluted EPS | -$9.36 |
News
See moreYahoo Finance • 30 days ago
Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment
Yahoo Finance • 3 months ago
Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.
Yahoo Finance • 3 months ago
Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update
Yahoo Finance • 3 months ago
Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025
About
CEO | Mr. Timothy Mark Dyer |
Address | Chemin des Mines, 9, Geneva, Switzerland, 1202 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2 |
